Lu Han
- Cancer Research top 10%
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Molecular Medicine top 10%
- Oral Surgery top 5%
- Reproductive Medicine top 10%
-
- Metabolomics and Mass Spectrometry Studies 7
-
- Estrogen and related hormone effects 7
-
- Acute Myocardial Infarction Research 7
-
- Effects and risks of endocrine disrupting chemicals 7
-
- Cardiac Imaging and Diagnostics 6
-
- Advanced Chemical Sensor Technologies 6
- Journals
- Frontiers in Oncology (5 papers)Journal of Chromatography A (4 papers)Journal of the American Heart Association (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lu Han
104 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 142
- Cancer Research 210
- Molecular Medicine 50
- Oral Surgery 62
- Reproductive Medicine 57
- Molecular Biology 442
Countries citing papers authored by Lu Han
This map shows the geographic impact of Lu Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Han more than expected).
Fields of papers citing papers by Lu Han
This network shows the impact of papers produced by Lu Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Han. The network helps show where Lu Han may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lu Han, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 28 | |
| 15 | 2022 | 6 | |
| 16 | 2022 | 24 | |
| 17 | LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis | 2020 | 1 |
| 18 | 2018 | 8 | |
| 19 | 2017 | 8 | |
| 20 | 2015 | 6 |
About Lu Han
Lu Han is a scholar working on Cancer Research, Molecular Medicine and Otorhinolaryngology, having authored 113 papers that have together received 1.4k indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (7 papers), Estrogen and related hormone effects (7 papers), Acute Myocardial Infarction Research (7 papers), Effects and risks of endocrine disrupting chemicals (7 papers), Cardiac Imaging and Diagnostics (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Advanced Chemical Sensor Technologies (6 papers). The work is most often cited by research in Cancer Research (210 citations), Molecular Medicine (50 citations) and Oral Surgery (62 citations). Lu Han has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Changcai Bai, Yushi Luan, Xiaoyan Li, Haitao Tao, Xinxin Deng, Ruizhou Wang, Qiling Li, Xiaojuan Gao, Dennis T. Ko and Jun Meng. Their work appears in journals such as Frontiers in Oncology, Journal of Chromatography A, Journal of the American Heart Association, Food and Chemical Toxicology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.